Literature DB >> 33262459

The spatial phenotype of genotypically distinct meningiomas demonstrate potential implications of the embryology of the meninges.

Daniel M Fountain1, Miriam J Smith2, Claire O'Leary3, Omar N Pathmanaban3, Federico Roncaroli3, Nicoletta Bobola4, Andrew T King3, Dafydd Gareth Evans2.   

Abstract

Meningiomas are the most common primary brain tumor and their incidence and prevalence is increasing. This review summarizes current evidence regarding the embryogenesis of the human meninges in the context of meningioma pathogenesis and anatomical distribution. Though not mutually exclusive, chromosomal instability and pathogenic variants affecting the long arm of chromosome 22 (22q) result in meningiomas in neural-crest cell-derived meninges, while variants affecting Hedgehog signaling, PI3K signaling, TRAF7, KLF4, and POLR2A result in meningiomas in the mesodermal-derived meninges of the midline and paramedian anterior, central, and ventral posterior skull base. Current evidence regarding the common pathways for genetic pathogenesis and the anatomical distribution of meningiomas is presented alongside existing understanding of the embryological origins for the meninges prior to proposing next steps for this work.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33262459     DOI: 10.1038/s41388-020-01568-6

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  68 in total

Review 1.  Histological classification and molecular genetics of meningiomas.

Authors:  Markus J Riemenschneider; Arie Perry; Guido Reifenberger
Journal:  Lancet Neurol       Date:  2006-12       Impact factor: 44.182

Review 2.  Contemporary surgical outcome for skull base meningiomas.

Authors:  Chien-Min Chen; Abel Po-Hao Huang; Lu-Ting Kuo; Yong-Kwang Tu
Journal:  Neurosurg Rev       Date:  2011-05-26       Impact factor: 3.042

Review 3.  Germline and somatic mutations in meningiomas.

Authors:  Miriam J Smith
Journal:  Cancer Genet       Date:  2015-02-19

4.  Prostaglandin D synthase (beta-trace) in human arachnoid and meningioma cells: roles as a cell marker or in cerebrospinal fluid absorption, tumorigenesis, and calcification process.

Authors:  T Yamashima; K Sakuda; Y Tohma; J Yamashita; H Oda; D Irikura; N Eguchi; C T Beuckmann; Y Kanaoka; Y Urade; O Hayaishi
Journal:  J Neurosci       Date:  1997-04-01       Impact factor: 6.167

5.  Identification of a progenitor cell of origin capable of generating diverse meningioma histological subtypes.

Authors:  M Kalamarides; A O Stemmer-Rachamimov; M Niwa-Kawakita; F Chareyre; E Taranchon; Z-Y Han; C Martinelli; E A Lusis; B Hegedus; D H Gutmann; M Giovannini
Journal:  Oncogene       Date:  2011-01-17       Impact factor: 9.867

6.  Advances in multidisciplinary therapy for meningiomas.

Authors:  Priscilla K Brastianos; Evanthia Galanis; Nicholas Butowski; Jason W Chan; Ian F Dunn; Roland Goldbrunner; Christel Herold-Mende; Franziska M Ippen; Christian Mawrin; Michael W McDermott; Andrew Sloan; James Snyder; Ghazaleh Tabatabai; Marcos Tatagiba; Joerg C Tonn; Patrick Y Wen; Kenneth Aldape; Farshad Nassiri; Gelareh Zadeh; Michael D Jenkinson; David R Raleigh
Journal:  Neuro Oncol       Date:  2019-01-14       Impact factor: 12.300

7.  Surgical outcomes after reoperation for recurrent skull base meningiomas.

Authors:  Stephen T Magill; David S Lee; Adam J Yen; Calixto-Hope G Lucas; David R Raleigh; Manish K Aghi; Philip V Theodosopoulos; Michael W McDermott
Journal:  J Neurosurg       Date:  2018-05-04       Impact factor: 5.115

8.  Biochemical analysis and solubilization of central alpha 1-adrenoceptors in the rat.

Authors:  P Guicheney; A Rappaport; P Meyer
Journal:  Chest       Date:  1983-02       Impact factor: 9.410

9.  Recurrence and outcome in skull base meningiomas: do they differ from other intracranial meningiomas?

Authors:  Anil Nanda; Prasad Vannemreddy
Journal:  Skull Base       Date:  2008-07

10.  Correspondence of tumor localization with tumor recurrence and cytogenetic progression in meningiomas.

Authors:  Ralf Ketter; Jörg Rahnenführer; Wolfram Henn; Yoo-Jin Kim; Wolfgang Feiden; Wolf-Ingo Steudel; Klaus D Zang; Steffi Urbschat
Journal:  Neurosurgery       Date:  2008-01       Impact factor: 4.654

View more
  2 in total

Review 1.  Synthesizing Molecular and Immune Characteristics to Move Beyond WHO Grade in Meningiomas: A Focused Review.

Authors:  Nivedha V Kannapadi; Pavan P Shah; Dimitrios Mathios; Christopher M Jackson
Journal:  Front Oncol       Date:  2022-05-31       Impact factor: 5.738

2.  Clinical significance of NF2 alteration in grade I meningiomas revisited; prognostic impact integrated with extent of resection, tumour location, and Ki-67 index.

Authors:  Yu Teranishi; Atsushi Okano; Satoru Miyawaki; Kenta Ohara; Daiichiro Ishigami; Hiroki Hongo; Shogo Dofuku; Hirokazu Takami; Jun Mitsui; Masako Ikemura; Daisuke Komura; Hiroto Katoh; Tetsuo Ushiku; Shumpei Ishikawa; Masahiro Shin; Hirofumi Nakatomi; Nobuhito Saito
Journal:  Acta Neuropathol Commun       Date:  2022-05-15       Impact factor: 7.578

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.